|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.35 SEK | +10.39% |
|
+7.72% | -5.53% |
| 06-23 | Citadel Back as Public Short Seller in Synact Pharma | FW |
| 06-18 | Edison Maintains Its Valuation for Synact Pharma After Trial Results | FW |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +10.39% | +7.72% | +55.84% | +17.83% | -5.53% | +6.22% | -71.53% | -81.17% | - | 106M | |
| +0.09% | +0.25% | +6.31% | +27.40% | +13.24% | +54.65% | +168.55% | +417.87% | +1,437.72% | 1,084B | |
| -1.63% | -1.50% | +9.32% | +7.37% | +25.20% | +65.79% | +62.43% | +52.64% | +110.77% | 634B | |
| -1.12% | -4.27% | +10.86% | +17.66% | +9.37% | +31.10% | +85.82% | +114.37% | +288.36% | 447B | |
| +0.18% | +2.04% | +3.97% | +6.81% | +2.22% | +30.19% | +26.51% | -5.21% | +31.83% | 330B | |
| -6.22% | -3.61% | -3.20% | -12.24% | -3.16% | +29.15% | +32.09% | +55.48% | +191.95% | 295B | |
| -1.27% | -0.56% | +5.93% | +2.57% | +13.41% | +27.21% | +46.39% | +47.78% | +53.84% | 285B | |
| -0.93% | -1.19% | +17.70% | +33.34% | -1.57% | -28.85% | -40.38% | +18.09% | +74.37% | 218B | |
| -1.19% | -2.81% | +5.53% | +2.26% | +11.09% | +22.63% | +61.80% | +48.30% | +127.01% | 199B | |
| -0.72% | +2.72% | +7.44% | -5.10% | +9.86% | +19.07% | +78.15% | +97.65% | +56.34% | 169B | |
| +0.83% | -0.29% | -5.64% | -10.91% | -2.61% | -5.13% | -32.03% | -38.78% | -32.92% | 137B | |
| -0.39% | -5.97% | +11.38% | +11.13% | +9.52% | +3.66% | +44.14% | +150.56% | +451.05% | 127B | |
| +0.70% | -0.33% | +2.58% | -2.57% | +7.42% | +21.57% | -7.27% | -13.73% | -23.15% | 118B | |
| -1.01% | +1.53% | +2.43% | -7.79% | +7.40% | +38.58% | +48.90% | +9.93% | -5.14% | 105B | |
| +1.47% | +4.70% | -0.25% | -5.43% | -7.54% | -8.22% | -18.59% | -10.84% | +3.09% | 103B | |
| +0.19% | +1.07% | -1.42% | -17.16% | -10.72% | +6.62% | +88.35% | +74.59% | +499.92% | 74.31B | |
| +2.14% | +3.47% | +42.06% | +25.25% | +36.99% | +86.53% | +3.98% | +0.20% | -44.24% | 55.6B | |
| +2.96% | +3.40% | +21.05% | -3.20% | -6.65% | +4.14% | +14.92% | -9.39% | +269.59% | 52.46B | |
| -0.97% | +4.82% | +6.89% | -6.75% | +11.64% | +22.88% | +22.40% | +47.89% | +26.92% | 52.94B | |
| -0.91% | +2.77% | +8.82% | -2.36% | -3.90% | -2.96% | +16.65% | - | - | 42.83B | |
| Average | +0.01% | +2.13% | +10.38% | +3.91% | +5.78% | +21.24% | +31.56% | +51.38% | +195.41% | 226.39B | |
| Weighted average by Cap. | -0.98% | +2.37% | +6.88% | +10.21% | +9.88% | +34.17% | +71.06% | +137.22% | +443.96% |
- Stock Market
- Stocks
- SYNACT Stock
- Sector SynAct Pharma AB
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
